AKT1 and ischemia reperfusion injury: MSC-Exo treatment in murine myocardium increases ATP and NADH levels, decreases oxidative stress, and enhances phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT) pro-survival signalling activation in ischemia-reperfusion injury (I/R) hearts [51].